Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2018

Every FDA drug recall initiated in 2018, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,681 recalls, newest first.

Class II · Moderate risk

Catapres .2

Failed Dissolution Specifications: OOS resultsduring routine stability testing

Terminated Dissolution failure Boehringer Ingelheim Pharmaceuticals, Inc. NDC 0597-0007-01 D-0128-2019
Class II · Moderate risk

children's allergy relief

Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.

Terminated Impurity / degradation Taro Pharmaceuticals U.S.A., Inc. D-0278-2019
Class II · Moderate risk

children's allergy

Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.

Terminated Impurity / degradation Taro Pharmaceuticals U.S.A., Inc. NDC 56062-106-08 D-0277-2019
Class II · Moderate risk

Children's 24 Hour Allergy

Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.

Terminated Impurity / degradation Taro Pharmaceuticals U.S.A., Inc. NDC 41250-106-08 D-0276-2019

Recalls by year